Literature DB >> 17008165

Serious hazards of transfusion: a decade of hemovigilance in the UK.

Dorothy Stainsby1, Hilary Jones, Deborah Asher, Claire Atterbury, Aysha Boncinelli, Lisa Brant, Catherine E Chapman, Katy Davison, Rebecca Gerrard, Alexandra Gray, Susan Knowles, Elizabeth M Love, Clare Milkins, D Brian L McClelland, Derek R Norfolk, Kate Soldan, Clare Taylor, John Revill, Lorna M Williamson, Hannah Cohen.   

Abstract

The Serious Hazards of Transfusion (SHOT) scheme is a UK-wide, independent, professionally led hemovigilance system focused on learning from adverse events. SHOT was established in 1996 as a confidential reporting system for significant transfusion-related events, building an evidence base to support blood safety policy decisions, clinical guidelines, clinician education, and improvements in transfusion practice. Recommendations are formulated by an independent steering group drawn from medical royal colleges and professional bodies. Ten years after its inception, SHOT has analyzed 2630 transfusion safety events, published 8 annual reports with recommendations, and presented data nationally and internationally. These recommendations have underpinned key initiatives, in particular the UK Department of Health "Better Blood Transfusion" strategy. SHOT has encouraged open reporting of adverse events and "near-misses" in a supportive, learning culture, vigilance in hospital transfusion practice, and evaluation of information technology to support this process. The importance of education and training has been emphasized. Detailed analysis of events has identified weaknesses in the transfusion chain. A collaborative initiative between SHOT, the Chief Medical Officer for England's National Blood Transfusion Committee, and the National Patient Safety Agency aims to reduce ABO-incompatible transfusions by improving bedside practice. Cumulative SHOT data have documented the decline in transfusion-related graft vs host disease after implementation of leucodepletion and have highlighted transfusion-related acute lung injury and bacterial contamination of platelets as important causes of death and morbidity. The UK blood services have developed strategies to reduce these risks. Future SHOT data will evaluate the success of these and other blood safety improvements.

Entities:  

Mesh:

Year:  2006        PMID: 17008165     DOI: 10.1016/j.tmrv.2006.05.002

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN: 0887-7963


  66 in total

Review 1.  On the role of iron therapy for reducing allogeneic blood transfusion in orthopaedic surgery.

Authors:  Manuel Muñoz; José Antonio García-Erce; Jorge Cuenca; Elvira Bisbe; Enrique Naveira
Journal:  Blood Transfus       Date:  2011-11-30       Impact factor: 3.443

Review 2.  Transfusion medicine and proteomics. Alliance or coexistence?

Authors:  Thomas Thiele; Leif Steil; Uwe Völker; Andreas Greinacher
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

3.  Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME).

Authors:  Elliott Vichinsky; Lynne Neumayr; Sean Trimble; Patricia J Giardina; Alan R Cohen; Thomas Coates; Jeanne Boudreaux; Ellis J Neufeld; Kristy Kenney; Althea Grant; Alexis A Thompson
Journal:  Transfusion       Date:  2013-07-25       Impact factor: 3.157

Review 4.  Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies.

Authors:  Kathryn E Webert; Christine M Cserti; Judy Hannon; Yulia Lin; Katerina Pavenski; Jacob M Pendergrast; Morris A Blajchman
Journal:  Transfus Med Rev       Date:  2008-01

Review 5.  Reduction of the risk of bacterial contamination of blood components through diversion of the first part of the donation of blood and blood components.

Authors:  Giancarlo Maria Liumbruno; Liviana Catalano; Vanessa Piccinini; Simonetta Pupella; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2009-04       Impact factor: 3.443

6.  The first data from the haemovigilance system in Italy.

Authors:  Adele Giampaolo; Vanessa Piccinini; Liviana Catalano; Francesca Abbonizio; Hamisa Jane Hassan
Journal:  Blood Transfus       Date:  2007-04       Impact factor: 3.443

7.  Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma.

Authors:  Giancarlo Maria Liumbruno; Maria Laura Sodini; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2008-01       Impact factor: 3.443

8.  Safety in transfusion medicine.

Authors:  Giuseppe Aprili
Journal:  Blood Transfus       Date:  2008-07       Impact factor: 3.443

9.  Proteomics and transfusion medicine.

Authors:  Lello Zolla
Journal:  Blood Transfus       Date:  2008-04       Impact factor: 3.443

10.  Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document".

Authors:  Santiago R Leal-Noval; Manuel Muñoz; Marisol Asuero; Enric Contreras; José A García-Erce; Juan V Llau; Victoria Moral; José A Páramo; Manuel Quintana
Journal:  Blood Transfus       Date:  2013-06-17       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.